Viewing Study NCT03115333


Ignite Creation Date: 2025-12-25 @ 2:49 AM
Ignite Modification Date: 2025-12-31 @ 5:39 PM
Study NCT ID: NCT03115333
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-11-13
First Post: 2017-04-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: DSC-MRI in Measuring rCBV for Early Response to Bevacizumab in Patients With Recurrent Glioblastoma
Sponsor: ECOG-ACRIN Cancer Research Group
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module